Could an antidepressant boost psoriasis treatment?

NCT ID NCT07432815

First seen Feb 28, 2026 · Last updated Jun 22, 2026 · Updated 13 times

Summary

This study compares methotrexate alone versus methotrexate plus the antidepressant escitalopram in 40 adults with moderate to severe psoriasis and depression or anxiety. Over six months, researchers will measure skin improvement and mental health changes to see if the combination works better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kasralainy

    RECRUITING

    Cairo, Cairo Governorate, 11562, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

methotrexate and escitalopram

What this could lead to

If it works, this could point toward a better treatment approach for people with both psoriasis and depression or anxiety.

What could go wrong

This is a small, early-phase trial with only 40 participants, so results may not apply to everyone. The combination therapy may not work better than methotrexate alone.

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.